Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.

den Hertog, Heleen M; Vermeer, S E; Zandbergen, A A M; Achterberg, Sefanja; Dippel, Diederik W J; Algra, Ale; Kappelle, L J; Koudstaal, Peter J

den Hertog, Heleen M; Vermeer, S E; Zandbergen, A A M; Achterberg, Sefanja; Dippel, Diederik W J; Algra, Ale; Kappelle, L J; Koudstaal, Peter J.

Affiliation

den Hertog HM; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Int J Stroke ; 10(1): 105-9, 2015 Jan.

Article in En | MEDLINE | ID: mdl-23489282

Subject(s)

Hypoglycemic Agents/therapeutic use; Ischemic Attack, Transient/drug therapy; Metformin/therapeutic use; Stroke/drug therapy; Blood Glucose/drug effects; Female; Humans; Male; Middle Aged

Key words

TIA; antidiabetics; impaired glucose tolerance; ischemic stroke; metformin; secondary stroke prevention

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ischemic Attack, Transient / Stroke / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Stroke Year: 2015 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google